7876 - 7900 of 8587 Results
Title
Year
-
OPENTitle: Miro1 Impairment in a Parkinson’s At-Risk CohortJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2021.734273Best OA location URL: https://doi.org/10.3389/fnmol.2021.734273Citation Count: 14
-
OPENTitle: Oromandibular Dystonia: A Clinical Examination of 2,020 CasesJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.700714Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.700714/pdfCitation Count: 32
- APOE and MAPT Are Associated With Dementia in Neuropathologically Confirmed Parkinson's Disease2021OPENTitle: APOE and MAPT Are Associated With Dementia in Neuropathologically Confirmed Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.631145Best OA location URL: https://doi.org/10.3389/fneur.2021.631145Citation Count: 41
- Unmet Needs of People With Parkinson's Disease and Their Caregivers During COVID-19-Related Confinement: An Explorative Secondary Data Analysis2021OPENTitle: Unmet Needs of People With Parkinson's Disease and Their Caregivers During COVID-19-Related Confinement: An Explorative Secondary Data AnalysisJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2020.615172Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.615172/pdfCitation Count: 13
- Screen Fast, Screen Faster: A Pilot Study to Screen for Depressive Symptoms Using the Beck Depression Inventory Fast Screen in Parkinson's Disease With Mild Cognitive Impairment2021OPENTitle: Screen Fast, Screen Faster: A Pilot Study to Screen for Depressive Symptoms Using the Beck Depression Inventory Fast Screen in Parkinson's Disease With Mild Cognitive ImpairmentJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.640137Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.640137/pdfCitation Count: 17
- Clinical Features of Patients With Progressive Supranuclear Palsy in an US Insurance Claims Database2021OPENTitle: Clinical Features of Patients With Progressive Supranuclear Palsy in an US Insurance Claims DatabaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.571800Best OA location URL: https://doi.org/10.3389/fneur.2021.571800Citation Count: 23
- The Added Benefit of Opicapone When Used Early in Parkinson's Disease Patients With Levodopa-Induced Motor Fluctuations: A Post-hoc Analysis of BIPARK-I and -II2021OPENTitle: The Added Benefit of Opicapone When Used Early in Parkinson's Disease Patients With Levodopa-Induced Motor Fluctuations: A Post-hoc Analysis of BIPARK-I and -IIJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.754016Best OA location URL: https://doi.org/10.3389/fneur.2021.754016Citation Count: 10
- A Multimodal Imaging Approach Demonstrates Reduced Midbrain Functional Network Connectivity Is Associated With Freezing of Gait in Parkinson's Disease2021OPENTitle: A Multimodal Imaging Approach Demonstrates Reduced Midbrain Functional Network Connectivity Is Associated With Freezing of Gait in Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.583593Best OA location URL: https://doi.org/10.3389/fneur.2021.583593Citation Count: 13
-
OPENTitle: Genetic control of the human brain proteomeJournal Name: The American Journal of Human GeneticsPublisher: Elsevier BVVol: 108Issue #: 3Start Page: 400End Page: 410Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.ajhg.2021.01.012Best OA location URL: http://www.cell.com/article/S0002929721000124/pdfCitation Count: 86
- Amantadine ER (Gocovri®) Significantly Increases ON Time Without Any Dyskinesia: Pooled Analyses From Pivotal Trials in Parkinson's Disease2021OPENTitle: Amantadine ER (Gocovri®) Significantly Increases ON Time Without Any Dyskinesia: Pooled Analyses From Pivotal Trials in Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.645706Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.645706/pdfCitation Count: 21
- Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study2020OPENTitle: Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 2Start Page: 107End Page: 116Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30394-xBest OA location URL: http://hdl.handle.net/10044/1/85602Citation Count: 100
- Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial2021OPENTitle: Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 3Start Page: 182End Page: 192Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30489-0Best OA location URL: http://www.thelancet.com/article/S1474442220304890/pdfCitation Count: 113
-
OPENTitle: The mechanisms of smell loss after SARS-CoV-2 infectionJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 9Start Page: 693End Page: 695Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00202-7Best OA location URL: http://www.thelancet.com/article/S1474442221002027/pdfCitation Count: 12
-
OPENTitle: Prehospital scales in acute ischaemic stroke management – Authors' replyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 7Start Page: 504End Page: 505Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00169-1Best OA location URL: https://pure.eur.nl/en/publications/25abb6f2-0472-4754-8580-97e2533ac37aCitation Count: 1
- Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study2021OPENTitle: Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 3Start Page: 203End Page: 212Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30449-xBest OA location URL: http://hdl.handle.net/2445/214932Citation Count: 251
-
OPENTitle: Intracellular Thermometry to Study Protein Aggregation Related to Neurodegenerative DiseasesJournal Name: Trends in Biochemical SciencesPublisher: Elsevier BVVol: 46Issue #: 3Start Page: 251End Page: 252Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.tibs.2020.12.003Best OA location URL: http://www.cell.com/article/S096800042030308X/pdfCitation Count: 2
- Measuring Patient Preferences at the FDA Center for Devices and Radiological Health: Reflections and Projections2021OPENTitle: Measuring Patient Preferences at the FDA Center for Devices and Radiological Health: Reflections and ProjectionsJournal Name: Value in HealthPublisher: Elsevier BVVol: 24Issue #: 7Start Page: 1024End Page: 1029Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.jval.2021.01.009Best OA location URL: https://doi.org/10.1016/j.jval.2021.01.009Citation Count: 3
- High cerebrospinal amyloid-β 42 is associated with normal cognition in individuals with brain amyloidosis2021OPENTitle: High cerebrospinal amyloid-β 42 is associated with normal cognition in individuals with brain amyloidosisJournal Name: eClinicalMedicinePublisher: Elsevier BVVol: 38Issue #:Start Page: 100988End Page: 100988Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.eclinm.2021.100988Best OA location URL: https://doi.org/10.1016/j.eclinm.2021.100988Citation Count: 110
- Serum Neurofilament Light is elevated in COVID-19 Positive Adults in the ICU and is associated with Co-Morbid Cardiovascular Disease, Neurological Complications, and Acuity of Illness2021OPENTitle: Serum Neurofilament Light is elevated in COVID-19 Positive Adults in the ICU and is associated with Co-Morbid Cardiovascular Disease, Neurological Complications, and Acuity of IllnessJournal Name: Cardiology and Cardiovascular MedicinePublisher: Fortune JournalsVol: 05Issue #: 05Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.26502/fccm.92920221Best OA location URL: https://doi.org/10.26502/fccm.92920221Citation Count: 14
- Molecular Pathobiology of the Cerebrovasculature in Aging and in Alzheimers Disease Cases With Cerebral Amyloid Angiopathy2021OPENTitle: Molecular Pathobiology of the Cerebrovasculature in Aging and in Alzheimers Disease Cases With Cerebral Amyloid AngiopathyJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.658605Best OA location URL: https://doi.org/10.3389/fnagi.2021.658605Citation Count: 14
- Temporal Ordering of Inflammatory Analytes sTNFR2 and sTREM2 in Relation to Alzheimer's Disease Biomarkers and Clinical Outcomes2021OPENTitle: Temporal Ordering of Inflammatory Analytes sTNFR2 and sTREM2 in Relation to Alzheimer's Disease Biomarkers and Clinical OutcomesJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.676744Best OA location URL: https://doi.org/10.3389/fnagi.2021.676744Citation Count: 13
- TNFRSF1B Gene Variants and Related Soluble TNFR2 Levels Impact Resilience in Alzheimer's Disease2021OPENTitle: TNFRSF1B Gene Variants and Related Soluble TNFR2 Levels Impact Resilience in Alzheimer's DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.638922Best OA location URL: https://doi.org/10.3389/fnagi.2021.638922Citation Count: 18
-
OPENTitle: Altered Brain Functional Network in Subtypes of Parkinson's Disease: A Dynamic PerspectiveJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.710735Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2021.710735/pdfCitation Count: 24
- Hippocampal and Hippocampal-Subfield Volumes From Early-Onset Major Depression and Bipolar Disorder to Cognitive Decline2021OPENTitle: Hippocampal and Hippocampal-Subfield Volumes From Early-Onset Major Depression and Bipolar Disorder to Cognitive DeclineJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.626974Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2021.626974/pdfCitation Count: 20
- A French survey on the lockdown consequences of COVID-19 pandemic in Parkinson's disease. The ERCOPARK study2021OPENTitle: A French survey on the lockdown consequences of COVID-19 pandemic in Parkinson's disease. The ERCOPARK studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 89Issue #:Start Page: 128End Page: 133Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.07.013Best OA location URL: http://www.prd-journal.com/article/S1353802021002625/pdfCitation Count: 24